Month: July 2021

CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its second quarter 2021 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, August 11, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. Conference Call Dial-In & Webcast Information:Date: Wednesday, August 11, 2021Time: 8:30 AM Eastern TimeUnited States: 877-407-3982International: 201-493-6780Conference ID: 13722002Webcast: http://public.viavid.com/index.php?id=146013The conference...

DUNMORE, Pa., July 28, 2021 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its most recent dividend declaration and unaudited, consolidated financial results for the three and six month periods ended June 30, 2021. Dividend Declared The Board of Directors of Fidelity D & D Bancorp, Inc. (the “Company”) announced their declaration of the Company’s third quarter dividend of $0.30 per share to shareholders of record at the close of business on August 20, 2021, payable September 10, 2021. Unaudited Financial Information Net income for the three months ended June 30, 2021 was $5.7 million, or $1.13 diluted earnings per share, compared to $0.3 million, or $0.05 diluted earnings per share, for the three months ended June 30, 2020. The...

PARAMOUNT, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant-based foods, today announced it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021 after market close. The Company will host a conference call to discuss the results at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). Investors interested in participating in the live call can dial 877-300-8521 from the U.S. and 412-317-6026 internationally. A telephone replay will be available approximately two hours after the call concludes through Thursday, August 26, 2021, and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 internationally, and entering the confirmation ID 10159081. The call will be webcast and available on the Investors...

NEWARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (NASDAQ: SSTI), a leader in precision policing technology solutions that enable law enforcement to more effectively respond to, investigate and deter crime, will hold a conference call on Tuesday, August 10, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2021. Financial results will be issued in a press release prior to the call. ShotSpotter management will host the presentation, followed by a question-and-answer period. Date: Tuesday August 10, 2021Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)U.S. dial-in: 1-855-327-6838International dial-in: 1-604-235-2082Conference ID: 10015933 A live audio webcast of the conference call will be available in listen-only mode simultaneously...

SOUTH SAN FRANCISCO, Calif., July 28, 2021 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from July 13, 2021, through July 27, 2021, the Compensation Committee of the Board of Directors (the “Board”) granted 3 new employees stock-based awards covering an aggregate of 41,900 shares of UNITY common stock, including options to purchase an aggregate of 41,900 shares of UNITY common stock. The stock-based awards were granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board in March 2020 to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market Rule...

Company Also Sees Jump in Margins and Sponsorship Fees in Bowling Green Tampa, FL, July 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to report a new Company record for single-weekend revenues driven by two strong B2 Fighting Series events this past weekend in Bowling Green, Kentucky. Brandon ‘Hardrock’ Higdon, B2’s Matchmaker, commented: “An amazing weekend of fights showcased 50 fighters and entertained the crowd for two nights. Cameron VanCamp wins again and has to be the top unsigned pro fighter in the country. We have another Canadian champion in Adam Assenza as he won his 4th in a row. The Ultimate Fighter alumni Prince McLean made his long-awaited return and won by KO in exciting...

Webcasted Presentation to Be Held Wednesday, August 11th CINCINNATI, July 28, 2021 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company” or “Quipt”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that members of its management team will host a webcasted presentation and participate in 1×1 meetings at the 41st Annual Canaccord Growth Conference on August 10-12, 2021. Webcasted Presentation Event: Canaccord Growth ConferenceDate: Wednesday, August 11, 2021Time: 8:30am EDT The live webcast of the presentation will be available by visiting the investors’ section of the company’s website at www.quipthomemedical.com. The webcast will also be available for replay on the company’s website following the event. ABOUT...

Deferral of filing of financial results for first quarter ended June 30, 2021 MONTREAL, July 28, 2021 (GLOBE NEWSWIRE) — D-BOX Technologies Inc. (“D-BOX” or the “Corporation”) (TSX: DBO), a world leader in haptic and immersive entertainment, announces that the Corporation is gradually resuming its activities following a ransomware cyberattack against its internal IT systems announced on July 14, 2021. All major IT systems have been restored and the restoration work should be finalized in the next few weeks. Production was never completely interrupted, and recovery of its various internal IT systems has begun. Although the release of the Corporation’s unaudited and condensed interim consolidated financial statements and management’s discussion and analysis for the quarter ended June 30, 2021 (the “Required Filings”)...

– 100% of ZF’s electricity use in North America will be attributed to renewable energy by 2030 – Represents a major step toward ZF global carbon neutrality goalsZF’s Electronics and Advanced Driver Assist Systems headquarters in Farmington Hills, Michigan will be attributing 100% of its electricity use to DTE’s renewable energy projects by 2030.ZF’s Marysville, Michigan manufacturing facility is among more than a dozen Michigan facilities that will benefit from DTE’s MIGreenPower program.Detroit, July 28, 2021 (GLOBE NEWSWIRE) — DTE Energy (NYSE: DTE) and ZF North America, Inc., one of the world’s leading automotive suppliers, today announced ZF North America’s enrollment in DTE’s MIGreenPower program. MIGreenPower is a voluntary renewable energy program that enables DTE...

UPGRADE umbrella study designed to evaluate UpRi in combination with other therapies, starting with carboplatin CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the initiation of patient dosing in UPGRADE, a Phase 1 combination dose escalation umbrella study to evaluate the safety and efficacy of upifitamab rilsodotin (UpRi, previously XMT-1536) in combination with other ovarian cancer therapies. The initial arm of this umbrella study is evaluating carboplatin in combination with UpRi followed by continuation of UpRi monotherapy in patients with platinum-sensitive ovarian cancer. “The initiation...